Having demonstrated that Thio-2 inhibits AR signaling and the growth of prostate cancer models independent of BAG-1 isoform function, we investigated whether its mechanism of action may be mediated through the AR NTD as it has previously been shown to inhibit AR NTD transactivation (15). Here, BAG1 is linked to prostate carcinoma.